Marta Kubera Selected Research

prepro-thyrotropin-releasing hormone

3/2005

Effects of PRI-2191--a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Kubera Research Topics

Disease

15	Inflammation (Inflammations) 01/2018 - 12/2007
13	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2022 - 08/2007
11	Fatigue 01/2022 - 08/2007
6	Schizophrenia (Dementia Praecox) 02/2020 - 11/2003
6	Neoplasms (Cancer) 01/2018 - 11/2009
5	Depressive Disorder (Melancholia) 02/2020 - 11/2009
5	Contact Dermatitis (Eczema, Contact) 01/2017 - 01/2012
5	Neuroblastoma 11/2009 - 04/2004
5	Treatment-Resistant Depressive Disorder 11/2009 - 02/2004
4	Mood Disorders (Mood Disorder) 01/2022 - 01/2013
4	Melanoma (Melanoma, Malignant) 01/2013 - 11/2009
3	Wounds and Injuries (Trauma) 01/2022 - 12/2010
3	Psychotic Disorders (Schizoaffective Disorder) 02/2020 - 11/2002
3	Neoplasm Metastasis (Metastasis) 01/2018 - 11/2009
3	Anhedonia 07/2017 - 07/2013
3	Medically Unexplained Symptoms 09/2013 - 02/2012
3	Infections 02/2012 - 08/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011 - 01/2009
3	Seizures (Absence Seizure) 09/2007 - 11/2003
2	Bipolar Disorder (Manic Depressive Psychosis) 02/2020 - 02/2020
2	Obesity 03/2018 - 01/2011
2	Insulin Resistance 03/2018 - 01/2013
2	Brain Diseases (Brain Disorder) 01/2017 - 01/2011
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 02/2012 - 01/2011
2	Mental Disorders (Mental Disorder) 01/2010 - 01/2007
2	Heart Failure 01/2009 - 01/2009
2	Cocaine-Related Disorders (Cocaine Addiction) 08/2008 - 01/2004
2	Pain (Aches) 07/2008 - 08/2007
1	Hypoxia (Hypoxemia) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 02/2020
1	Dysbiosis 02/2020
1	Treatment-Resistant Schizophrenia 02/2020
1	Adenocarcinoma 01/2018
1	Mania (Manias) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018

Drug/Important Bio-Agent (IBA)

18	Antidepressive Agents (Antidepressants)IBA 01/2018 - 02/2004
7	CytokinesIBA 02/2020 - 11/2009
7	Immunoglobulin M (IgM)IBA 02/2020 - 02/2008
7	Fluoxetine (Prozac)FDA LinkGeneric 01/2013 - 02/2004
6	Desipramine (Pertofrane)FDA LinkGeneric 01/2018 - 11/2009
5	Interleukin-10 (Interleukin 10)IBA 02/2020 - 12/2011
5	Immunoglobulin A (IgA)IBA 02/2020 - 02/2008
5	Tryptophan (L-Tryptophan)FDA Link 02/2020 - 12/2007
5	GlucocorticoidsIBA 03/2018 - 01/2007
5	AntibodiesIBA 09/2013 - 01/2010
5	AntioxidantsIBA 04/2011 - 06/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2011
4	Pharmaceutical PreparationsIBA 01/2016 - 01/2004
4	CorticosteroneIBA 03/2014 - 07/2008
4	NeopterinIBA 02/2012 - 01/2012
3	EpitopesIBA 02/2020 - 02/2012
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2018 - 12/2004
3	Sucrose (Saccharose)IBA 07/2017 - 07/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2013
3	AntigensIBA 10/2015 - 01/2013
3	HaptensIBA 10/2015 - 01/2013
3	InterferonsIBA 03/2014 - 01/2011
3	LipopolysaccharidesIBA 02/2012 - 02/2004
3	Antipsychotic Agents (Antipsychotics)IBA 01/2011 - 11/2002
3	EnzymesIBA 12/2010 - 12/2007
3	StaurosporineIBA 11/2009 - 07/2007
3	Cocaine (Cocaine HCl)IBA 08/2008 - 11/2003
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
2	ChemokinesIBA 02/2020 - 01/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2020 - 01/2016
2	KynurenineIBA 08/2019 - 12/2007
2	Kynurenic Acid (Kynurenate)IBA 01/2018 - 12/2007
2	Serotonin (5 Hydroxytryptamine)IBA 09/2013 - 02/2012
2	MitogensIBA 01/2013 - 06/2004
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013 - 11/2009
2	Interleukin-1 (Interleukin 1)IBA 02/2012 - 02/2012
2	Muramidase (Lysozyme)IBA 02/2012 - 02/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2011 - 03/2005
2	Phosphotransferases (Kinase)IBA 04/2011 - 11/2003
2	PeroxidesIBA 04/2011 - 09/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 11/2009
2	Amantadine (Aman)FDA LinkGeneric 11/2009 - 11/2009
2	coenzyme Q10 (CoQ10)IBA 01/2009 - 01/2009
2	Dehydroepiandrosterone SulfateIBA 09/2008 - 11/2003
2	NeurosteroidsIBA 09/2008 - 11/2003
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2008 - 11/2006
2	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 07/2007 - 11/2006
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	CateninsIBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 02/2020
1	Complement System Proteins (Complement)IBA 02/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2020
1	HaptoglobinsIBA 02/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2020
1	Insulin (Novolin)FDA Link 03/2018
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2018
1	Neuroprotective AgentsIBA 03/2018
1	monoaminocarboxydihydroboraneIBA 01/2018
1	tianeptine (Stablon)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2004